(Circulation. 1996;93:2068-2079.)
© 1996 American Heart Association, Inc.
Articles |
Endothelin-1 Is Involved in Norepinephrine-Induced Ventricular Hypertrophy In Vivo
Acute Effects of Bosentan, an Orally Active, Mixed Endothelin ETA and ETB Receptor Antagonist
From the National Heart and Lung Institute, Imperial College, London (S.K., K.R.B., P.H.S., P.A.P.-W.); Royal Brompton Hospital, London (S.K., P.A.P.-W.); and the Institute of Molecular Medicine, John Radcliffe Hospital, Oxford (J.D.F.), England.
Correspondence to Dr Samer Kaddoura, Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College, London SW3 6LY, England, UK. E-mail s.kaddoura@ic.ac.uk.
Background Endothelin-1 (ET-1) has potent effects on cell growth and induces hypertrophy of cultured ventricular myocytes. Catecholamines increase expression of ET-1 mRNA by cultured myocytes. We investigated the role of endogenous ET-1 in catecholamine-induced hypertrophy in vivo by studying the effects of continuous norepinephrine infusion on physical and molecular markers of ventricular hypertrophy, ventricular and noncardiac expression of ET-1 mRNA, and the acute effects of bosentan, an orally active ETA and ETB receptor antagonist.
Methods and Results Seventy male Sprague-Dawley
rats (175 to 200 g) were divided into four groups: (1)
sham-operated rats, (2) norepinephrine-infused rats
(600
µg·kg-1·h-1
by subcutaneous osmotic pump, up to 7 days), (3) sham-operated rats
given bosentan, and (4) norepinephrine-infused rats
given bosentan. Bosentan (100 mg/kg once daily) was administered by
gavage for 6 days starting 1 day before operation.
Norepinephrine caused increases in absolute
ventricular weight and ratios of ventricular
weight to body weight and ventricular RNA to protein.
Ventricular expression of mRNAs for atrial
natriuretic factor, skeletal 
-actin, and
ß-myosin heavy chain, which in adult rat ventricle are indicators
of hypertrophy, also increased. Ventricular
expression of ET-1 mRNA was elevated in the norepinephrine
group at 1, 2, and 3 days. By 5 days, this had fallen to control
levels. In lung, kidney, and skeletal muscle,
norepinephrine did not significantly increase expression of
ET-1 mRNA. Bosentan attenuated norepinephrine-induced
increases in ventricular weight, ratio of RNA to protein,
and expression of skeletal -actin mRNA and ß-myosin heavy
chain mRNA at 5 days, but it did not attenuate increased
ventricular expression of atrial natriuretic
factor mRNA.
Conclusions These data suggest that endogenous ET-1 plays a direct role in mediating norepinephrine-induced ventricular hypertrophy in vivo.
Key Words: endothelin • hypertrophy • RNA • norepinephrine • bosentan
This article has been cited by other articles:
 |
|
 |
|
  M. Clozel, P. Hess, M. Rey, M. Iglarz, C. Binkert, and C. Qiu Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 967 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jesmin, Y. Hattori, S. Maeda, S. Zaedi, I. Sakuma, and T. Miyauchi Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2146 - H2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. De Acetis, A. Notte, F. Accornero, G. Selvetella, M. Brancaccio, C. Vecchione, M. Sbroggio, F. Collino, B. Pacchioni, G. Lanfranchi, et al. Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload Circ. Res., May 27, 2005; 96(10): 1087 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hlaing, P. Spitz, K. Padmanabhan, B. Cabezas, C. S. Barker, and H. S. Bernstein E2F-1 Regulates the Expression of a Subset of Target Genes during Skeletal Myoblast Hypertrophy J. Biol. Chem., October 15, 2004; 279(42): 43625 - 43633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iemitsu, T. Miyauchi, S. Maeda, T. Tanabe, M. Takanashi, M. Matsuda, and I. Yamaguchi Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1696 - H1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Motte, R. van Beneden, J. Mottet, B. Rondelet, M. Mathieu, X. Havaux, P. Lause, C. Clercx, J.-M. Ketelslegers, R. Naeije, et al. Early activation of cardiac and renal endothelin systems in experimental heart failure Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2482 - H2491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Lips, L. J. deWindt, D. J.W. van Kraaij, and P. A. Doevendans Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy Eur. Heart J., May 2, 2003; 24(10): 883 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nahrendorf, K. Hu, D. Fraccarollo, K.-H. Hiller, A. Haase, W. R. Bauer, and G. Ertl Time course of right ventricular remodeling in rats with experimental myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H241 - H248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2034 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nahrendorf, K. Hu, K.-H. Hiller, P. Galuppo, D. Fraccarollo, G. Schweizer, A. Haase, G. Ertl, W. R. Bauer, and J. Bauersachs Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: An experimental serial cardiac magnetic resonance imaging study J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1695 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fraccarollo, J. Bauersachs, M. Kellner, P. Galuppo, and G. Ertl Cardioprotection by long-term ETA receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy Cardiovasc Res, April 1, 2002; 54(1): 85 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Clozel, C. Qiu, C.-S. Qiu, P. Hess, and J.-P. Clozel Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction J. Am. Coll. Cardiol., January 2, 2002; 39(1): 142 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Kats, D. Methot, P. Paradis, D. W. Silversides, and T. L. Reudelhuber Use of a Biological Peptide Pump to Study Chronic Peptide Hormone Action in Transgenic Mice. DIRECT AND INDIRECT EFFECTS OF ANGIOTENSIN II ON THE HEART J. Biol. Chem., November 16, 2001; 276(47): 44012 - 44017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Packer, A. J.S. Coats, M. B. Fowler, H. A. Katus, H. Krum, P. Mohacsi, J. L. Rouleau, M. Tendera, A. Castaigne, E. B. Roecker, et al. Effect of Carvedilol on Survival in Severe Chronic Heart Failure N. Engl. J. Med., May 31, 2001; 344(22): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Endogenous Cyclic AMP-Adenosine Pathway Regulates Cardiac Fibroblast Growth Hypertension, April 1, 2001; 37(4): 1095 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hautala, H. Tokola, M. Luodonpaa, J. Puhakka, H. Romppanen, O. Vuolteenaho, and H. Ruskoaho Pressure Overload Increases GATA4 Binding Activity via Endothelin-1 Circulation, February 6, 2001; 103(5): 730 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Elijovich, C. L. Laffer, E. Amador, H. Gavras, M. R. Bresnahan, and E. L. Schiffrin Regulation of Plasma Endothelin by Salt in Salt-Sensitive Hypertension Circulation, January 16, 2001; 103(2): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ammarguellat, I. Larouche, and E. L. Schiffrin Myocardial Fibrosis in DOCA-Salt Hypertensive Rats : Effect of Endothelin ETA Receptor Antagonism Circulation, January 16, 2001; 103(2): 319 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Romppanen, J. Puhakka, G. Foldes, I. Szokodi, O. Vuolteenaho, H. Tokola, M. Toth, and H. Ruskoaho Endothelin-1-Independent and Angiotensin II-Independent Induction of Adrenomedullin Gene Expression Hypertension, January 1, 2001; 37(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1702 - 1711. [Abstract] [Full Text]
|
|
|
|
|
|
S. Sakai, T. Miyauchi, and I. Yamaguchi Long-Term Endothelin Receptor Antagonist Administration Improves Alterations in Expression of Various Cardiac Genes in Failing Myocardium of Rats With Heart Failure Circulation, June 20, 2000; 101(24): 2849 - 2853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Morimoto, K. Hasegawa, S. Kaburagi, T. Kakita, H. Wada, T. Yanazume, and S. Sasayama Phosphorylation of GATA-4 Is Involved in alpha 1-Adrenergic Agonist-responsive Transcription of the Endothelin-1 Gene in Cardiac Myocytes J. Biol. Chem., April 28, 2000; 275(18): 13721 - 13726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Gilbert, J. R. Rumble, Z. Cao, A. J. Cox, P. van Eeden, T. J. Allen, D. J. Kelly, and M. E. Cooper Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes Circ. Res., February 4, 2000; 86(2): 158 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mishima, M. Tanimura, G. Suzuki, A. Todor, V. G. Sharov, S. Goldstein, and H. N. Sabbah Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure J. Am. Coll. Cardiol., January 1, 2000; 35(1): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-E. Massart, J. Donckier, J. Kyselovic, T. Godfraind, G. R. Heyndrickx, and M. Wibo Carvedilol and Lacidipine Prevent Cardiac Hypertrophy and Endothelin-1 Gene Overexpression After Aortic Banding Hypertension, December 1, 1999; 34(6): 1197 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Larouche and E. L. Schiffrin Cardiac Microvasculature in DOCA-Salt Hypertensive Rats : Effect of Endothelin ETA Receptor Antagonism Hypertension, October 1, 1999; 34(4): 795 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ribadeau-Dumas, M. Brady, S. Y Boateng, K. Schwartz, and K. R Boheler Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development Cardiovasc Res, August 1, 1999; 43(2): 426 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure Circulation, April 27, 1999; 99(16): 2118 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yamauchi-Kohno, T. Miyauchi, T. Hoshino, T. Kobayashi, H. Aihara, S. Sakai, H. Yabana, K. Goto, Y. Sugishita, and S. Murata Role of Endothelin in Deterioration of Heart Failure Due to Cardiomyopathy in Hamsters : Increase in Endothelin-1 Production in the Heart and Beneficial Effect of Endothelin-A Receptor Antagonist on Survival and Cardiac Function Circulation, April 27, 1999; 99(16): 2171 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ehmke, J. Faulhaber, K. Munter, M. Kirchengast, and R. J. Wiesner Chronic ETA Receptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive Rats Hypertension, April 1, 1999; 33(4): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. DeFily, Y. Nishikawa, and W. M. Chilian Endothelin antagonists block alpha 1-adrenergic constriction of coronary arterioles Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1028 - H1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaburagi, K. Hasegawa, T. Morimoto, M. Araki, T. Sawamura, T. Masaki, and S. Sasayama The Role of Endothelin-Converting Enzyme-1 in the Development of {alpha}1-Adrenergic-Stimulated Hypertrophy in Cultured Neonatal Rat Cardiac Myocytes Circulation, January 19, 1999; 99(2): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwanaga, Y. Kihara, K. Hasegawa, K. Inagaki, T. Yoneda, S. Kaburagi, M. Araki, and S. Sasayama Cardiac Endothelin-1 Plays a Critical Role in the Functional Deterioration of Left Ventricles During the Transition From Compensatory Hypertrophy to Congestive Heart Failure in Salt-Sensitive Hypertensive Rats Circulation, November 10, 1998; 98(19): 2065 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Oie, R. Bjonerheim, H. K. Grogaard, H. Kongshaug, O. A. Smiseth, and H. Attramadal ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H868 - H877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hoshino, R. Yamauchi, K. Kikkawa, H. Yabana, and S. Murata Pharmacological Profile of T-0201, a Highly Potent and Orally Active Endothelin Receptor Antagonist J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 643 - 649. [Abstract] [Full Text]
|
|
|
|
|
|
M. U Koban, A. F.M Moorman, J. Holtz, M. H Yacoub, and K. R Boheler Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence Cardiovasc Res, February 1, 1998; 37(2): 405 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Herizi, B. Jover, N. Bouriquet, and A. Mimran Prevention of the Cardiovascular and Renal Effects of Angiotensin II by Endothelin Blockade Hypertension, January 1, 1998; 31(1): 10 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Magga, O. Vuolteenaho, M. Marttila, and H. Ruskoaho Endothelin-1 Is Involved in Stretch-Induced Early Activation of B-Type Natriuretic Peptide Gene Expression in Atrial but Not in Ventricular Myocytes : Acute Effects of Mixed ETA/ETB and AT1 Receptor Antagonists In Vivo and In Vitro Circulation, November 4, 1997; 96(9): 3053 - 3062. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Moser, J. Faulhaber, R. J. Wiesner, and H. Ehmke Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1389 - R1394. [Abstract] [Full Text] [PDF]
|
|